Answers are grounded in this paper and cite their sources.
The identification of RNF43 mutations in a distinct subset of IPNBs revealed a new molecular role in the pathogenesis of IPNB, and provided a potential application for cancer therapeutics by the use of Wnt pathway inhibitors.
No takes yet. Share an insight, caveat, or question.
Tsai et al. (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: